Skip to main content
. 2018 Jul 31;7(3):65. doi: 10.3390/pathogens7030065
BAL bronchoalveolar lavage
CNI calcineurin inhibitors
CNS central nervous system
CsA Cyclosporine
CSF cerebral spinal fluid
CMV Cytomegalovirus
D+/D− Toxoplasma-seropositive/seronegative donor
HSCT allogeneic haematopoietic stem cell transplant
mTORI mammalian target of rapamycin inhibitors
NCC Neurocysticercosis
PCR polymerase chain reaction
PTLD post-transplant lymphoproliferative disorder
R+/R− Toxoplasma-seropositive/seronegative recipient
SOLs intracranial space-occupying lesions
SOT solid organ transplantation
TAC Tacrolimus
TB Tuberculosis
TMP-SMZ trimethoprim-sulfamethoxazole
WB western blot